Evidence map›Paper›PMID 38580917›Full record

ArticleBMC genomics2024

HMGB1 prefers to interact with structural RNAs and regulates rRNA methylation modification and translation in HeLa cells.

Meimei Liao, Jiarui Cao, Wen Chen, Mengwei Wang, Zhihui Jin, Jia Ye, Yijun Ren, Yaxun Wei, Yaqiang Xue, Dong Chen and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Meimei LiaoDepartment of Ultrasound Imaging, Renmin Hospital of Wuhan University, Hubei, Wuhan, People's Republic of China.
Jiarui CaoDepartment of Orthopedics, Renmin Hospital of Wuhan University, Hubei, Wuhan, People's Republic of China.
Wen ChenCenter for Genome Analysis, ABLife Inc., Optics Valley International Biomedical Park, East Lake High-Tech Development Zone, 388 Gaoxin 2Nd Road, Hubei, Wuhan, 430075, China.
Mengwei WangDepartment of Orthopedics, Renmin Hospital of Wuhan University, Hubei, Wuhan, People's Republic of China.
Zhihui JinDepartment of Orthopedics, Renmin Hospital of Wuhan University, Hubei, Wuhan, People's Republic of China.
Jia YeDepartment of Orthopedics, Renmin Hospital of Wuhan University, Hubei, Wuhan, People's Republic of China.
Yijun RenDepartment of Orthopedics, Renmin Hospital of Wuhan University, Hubei, Wuhan, People's Republic of China.
Yaxun WeiCenter for Genome Analysis, ABLife Inc., Optics Valley International Biomedical Park, East Lake High-Tech Development Zone, 388 Gaoxin 2Nd Road, Hubei, Wuhan, 430075, China.
Yaqiang XueCenter for Genome Analysis, ABLife Inc., Optics Valley International Biomedical Park, East Lake High-Tech Development Zone, 388 Gaoxin 2Nd Road, Hubei, Wuhan, 430075, China.
Dong ChenCenter for Genome Analysis, ABLife Inc., Optics Valley International Biomedical Park, East Lake High-Tech Development Zone, 388 Gaoxin 2Nd Road, Hubei, Wuhan, 430075, China.
Yi ZhangCenter for Genome Analysis, ABLife Inc., Optics Valley International Biomedical Park, East Lake High-Tech Development Zone, 388 Gaoxin 2Nd Road, Hubei, Wuhan, 430075, China.
Sen ChenDepartment of Orthopedics, Renmin Hospital of Wuhan University, Hubei, Wuhan, People's Republic of China. ahsen1211@whu.edu.cn.
Renmin Hospital of Wuhan University · CNWuhan University · CN

Funding

Hubei Provincial Department of Health General Project WJ2021M139National Natural Science Foundation of China 81672154
6 · The paper itself

Abstract

backgroundHigh-mobility group B1 (HMGB1) is both a DNA binding nuclear factor modulating transcription and a crucial cytokine that mediates the response to both infectious and noninfectious inflammation such as autoimmunity, cancer, trauma, and ischemia reperfusion injury. HMGB1 has been proposed to control ribosome biogenesis, similar as the other members of a class of HMGB proteins.

resultsHere, we report that HMGB1 selectively promotes transcription of genes involved in the regulation of transcription, osteoclast differentiation and apoptotic process. Improved RNA immunoprecipitation by UV cross-linking and deep sequencing (iRIP-seq) experiment revealed that HMGB1 selectively bound to mRNAs functioning not only in signal transduction and gene expression, but also in axon guidance, focal adhesion, and extracellular matrix organization. Importantly, HMGB1-bound reads were strongly enriched in specific structured RNAs, including the domain II of 28S rRNA, H/ACA box snoRNAs including snoRNA63 and scaRNAs. RTL-P experiment showed that overexpression of HMGB1 led to a decreased methylation modification of 28S rRNA at position Am2388, Cm2409, and Gm2411. We further showed that HMGB1 overexpression increased ribosome RNA expression levels and enhanced protein synthesis.

conclusionTaken together, our results support a model in which HMGB1 binds to multiple RNA species in human cancer cells, which could at least partially contribute to HMGB1-modulated rRNA modification, protein synthesis function of ribosomes, and differential gene expression including rRNA genes. These findings provide additional mechanistic clues to HMGB1 functions in cancers and cell differentiation.

Indexed as

HMGB1 ProteinRNA MethylationHeLa CellsHumansMethylationRNA, Ribosomal, 28SRNA, Small NucleolarHMGB1 ProteinRNA, Ribosomal, 28SRNA, Small Nucleolar28S rRNACancer cellsHMGB1iRIP-seqMethylation modificationsnoRNAsStructured RNATranslation

Identifiers

PMID38580917
PMCPMC10996203
OpenAlexW4393991025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.